Archives
-
Spleen-Targeted mRNA Vaccine Builds TLS in HCC
2026-09-09
Lin et al. develop a spleen-targeted neoantigen mRNA vaccine that drives ISG15-positive CD8-positive T-cell responses, tertiary lymphoid structure formation, and strong antitumor activity in hepatocellular carcinoma models. The study links organ-selective delivery to a GZMA–F2R interaction between cytotoxic T cells and antigen-presenting cells, providing a mechanistic framework for next-generation mRNA vaccine design.
-
Five-Element Nanoparticles for Stable Lung mRNA Delivery
2026-09-09
Cao and colleagues developed helper-polymer-based five-element nanoparticles that combine poly(β-amino esters) with DOTAP to improve lung-directed mRNA delivery and formulation stability. The study links polymer structure, interparticle charge repulsion, hydrophobic cohesion, and lyophilization to a dried formulation that remained usable after storage at 4 °C for at least six months.
-
Arrb2, 6-ketoLCA, and Hepatic IRI
2026-09-08
This study identifies hepatocyte β-arrestin 2 (Arrb2) as a regulator of hepatic ischemia–reperfusion injury that links parenchymal stress to macrophage polarization through the metabolite 6-ketoLCA. Its combination of clinical-sample analysis, hepatocyte-targeted mouse genetics, ischemia–reperfusion modeling, hypoxia–reoxygenation assays, and metabolomics provides a useful framework for studying liver immune–metabolic communication.
-
Cy5-UTP for Mechanistic RNA Assay Design
2026-09-08
Cy5-UTP enables direct visualization of RNA produced by in vitro transcription while adding a powerful analytical layer to mRNA delivery studies. This guide explains how Cyanine 5-uridine triphosphate can distinguish RNA distribution from translation and immune function, using recent in situ TIL research as a practical framework.
-
HyperScript First-Strand cDNA Synthesis Kit for Ovarian RNA
2026-09-07
A translational strategy for connecting ovarian senescence biology with more defensible RNA-to-cDNA workflows, using the CTX–HCQ mtDNA–cGAS study as a model for assay design, validation, and interpretation.
-
EDC.HCl: Practical Coupling Workflow
2026-09-07
EDC.HCl is a water-soluble carbodiimide used to activate carboxyl groups for amide bond formation with primary amines in controlled laboratory workflows. It is suitable for in vitro peptide, bioconjugation, nucleotide, esterification, and lactonization chemistry, but the dossier provides no in vivo or clinical evidence.
-
p21-ELP1-Bac Delivery Suppresses Glioblastoma Growth
2026-09-05
Quinn, Shaheen, and Raucher show that an elastin-like polypeptide and cell-penetrating peptide can deliver a p21-derived inhibitor into U87, GBM43, and GBM6 glioblastoma cells. The construct suppressed proliferation primarily through cytostatic effects, while sustained intracellular localization and limited apoptosis supported a delivery-dependent mechanism that varied among cell lines.
-
EZ Cap™ Cy5 Firefly Luciferase mRNA: Assay Design
2026-09-04
Learn how EZ Cap Cy5 Firefly Luciferase mRNA can distinguish delivery, intracellular persistence, and functional translation in advanced formulation studies. This guide connects dual-reporter assay design with new MOF-based mRNA delivery evidence and practical decision points.
-
Artesunate Cancer Assays: Workflow & Optimization
2026-09-04
Artesunate is an artemisinin derivative for separating growth inhibition from true cancer-cell killing in time-resolved in vitro studies. This workflow emphasizes solvent control, orthogonal viability measurements, and mechanism-aware interpretation across small cell lung carcinoma and esophageal squamous cell carcinoma models.
-
B7H3×CD3 BiTE mRNA-LNPs in Cancer Therapy
2026-09-03
Huang et al. developed an ionizable lipid nanoparticle system for delivering mRNA encoding a B7H3×CD3 bispecific T-cell engager. The preclinical study links a single intravenous dose with strong in vivo protein expression, prolonged BiTE exposure, and durable antitumor activity in hematologic malignancy and melanoma models.
-
Tomivosertib in Human DRG Neurons: Key Findings
2026-09-03
The reference study tested MNK inhibition directly in cultured human dorsal root ganglion neurons obtained during surgery for radiculopathy. Tomivosertib rapidly and reversibly reduced spontaneous activity while producing molecular evidence of target engagement, strengthening the translational case for MNK signaling in neuropathic pain.
-
v-Agatoxin-IVA and N-Type Calcium Channel Blockade
2026-09-02
Sidach and Mintz showed that v-Agatoxin-IVA is not exclusively a high-affinity P-type channel blocker at micromolar concentrations: it also produces weaker, voltage-dependent inhibition of native N-type and other high-threshold calcium currents. The study refines toxin-based channel classification and cautions that low-affinity block can complicate Q-type functional assignments.
-
EZ Cap™ Firefly Luciferase mRNA Workflow Guide
2026-09-02
Build more interpretable mRNA delivery, translation, and gene regulation assays with a Cap1- and poly(A)-optimized luciferase reporter. This guide connects practical cell-based workflows with structure- and route-dependent insights from LNP research, including in vivo imaging and troubleshooting strategies.
-
ER-Targeting Peptide Assembly in Cancer Cells
2026-09-01
The reference study develops an alkaline-phosphatase-triggered peptide that self-assembles at the endoplasmic reticulum through a p-toluenesulfonamide targeting group. This organelle-focused enzyme-instructed self-assembly selectively increased ER stress and cancer-cell death, while lowering the reported IC50 by more than twofold relative to intracellular self-assembly without ER targeting.
-
Murine RNase Inhibitor for RNA Workflows
2026-09-01
Protect low-input RNA during RT-PCR, cDNA synthesis, transcription, and labeling workflows with an oxidation-resistant inhibitor designed for pancreatic-type RNases. Its low-DTT tolerance is especially useful when RNA integrity must be preserved without heavily reducing reaction chemistry.